Posters

Presenting Author Academic/Professional Position

Jose J Loayza Pintado / Resident Physician PGY2

Academic Level (Author 1)

Resident

Academic Level (Author 2)

Resident

Discipline/Specialty (Author 2)

Internal Medicine

Discipline Track

Clinical Science

Abstract Type

Research/Clinical

Abstract

Introduction: The comparative effects of oral versus transdermal estrogen therapy on cardiovascular parameters in postmenopausal women remain incompletely understood. This analysis aimed to evaluate blood pressure and heart rate responses between administration routes.

Methods: A systematic review of randomized trials comparing oral and transdermal estrogen therapy in postmenopausal women was conducted. Primary outcomes included changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate. Random-effects meta-analysis was performed to calculate pooled mean differences (MD) with 95% confidence intervals (CI).

Results: Analysis of 8 randomized trials (N=885) showed no significant differences between oral and transdermal routes in mean changes from baseline for SBP (MD=1.45 mmHg; 95% CI: -0.21 to 3.12; p=0.09) or DBP (MD=1.07 mmHg; 95% CI: -0.11 to 2.24; p=0.08). Heart rate changes were comparable between groups (MD=0.05; 95% CI: -1.43 to 1.52; p=0.95). Subgroup analysis by treatment duration (≤6 vs >6 months) revealed consistent blood pressure findings across follow-up periods.

Conclusions: Oral and transdermal estrogen demonstrate comparable effects on blood pressure and heart rate in postmenopausal women, suggesting both routes may be suitable from a cardiovascular perspective. These findings can help inform individualized treatment decisions regarding estrogen therapy administration route.

Presentation Type

Poster

Share

COinS
 

Cardiovascular Response Patterns to Oral versus Transdermal Estrogen Therapy in Postmenopausal Women

Introduction: The comparative effects of oral versus transdermal estrogen therapy on cardiovascular parameters in postmenopausal women remain incompletely understood. This analysis aimed to evaluate blood pressure and heart rate responses between administration routes.

Methods: A systematic review of randomized trials comparing oral and transdermal estrogen therapy in postmenopausal women was conducted. Primary outcomes included changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate. Random-effects meta-analysis was performed to calculate pooled mean differences (MD) with 95% confidence intervals (CI).

Results: Analysis of 8 randomized trials (N=885) showed no significant differences between oral and transdermal routes in mean changes from baseline for SBP (MD=1.45 mmHg; 95% CI: -0.21 to 3.12; p=0.09) or DBP (MD=1.07 mmHg; 95% CI: -0.11 to 2.24; p=0.08). Heart rate changes were comparable between groups (MD=0.05; 95% CI: -1.43 to 1.52; p=0.95). Subgroup analysis by treatment duration (≤6 vs >6 months) revealed consistent blood pressure findings across follow-up periods.

Conclusions: Oral and transdermal estrogen demonstrate comparable effects on blood pressure and heart rate in postmenopausal women, suggesting both routes may be suitable from a cardiovascular perspective. These findings can help inform individualized treatment decisions regarding estrogen therapy administration route.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.